Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions

@inproceedings{Sachs2017RiskPI,
  title={Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions},
  author={Mikkel Lindskov Sachs and Sofia K{\"a}lvemark Sporrong and Morten Colding-J{\o}rgensen and Sven Frokjaer and Per Helboe and Katarina Jelic and Susanne Kaae},
  booktitle={Pharmaceutical Medicine},
  year={2017}
}
Increasingly, patients are expected to influence decisions previously reserved for regulatory agencies, pharmaceutical companies, and healthcare professionals. Individual patients have previously represented their patient population when rare, serious adverse events (AEs) were weighed as part of a benefit-risk assessment. However, the degree of heterogeneity of the patient population is critical for how accurately they can be represented by individuals. This study aims to explore patients’ risk… CONTINUE READING
BETA
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 63 REFERENCES

Adverse drug reaction reports of patients

L Rolfes, F van Hunsel, S Wilkes, K van Grootheest, E. van Puijenbroek
  • Pharmacoepidemiol Drug Saf
  • 2015
VIEW 1 EXCERPT

How do general practitioners and patients make decisions about cardiovascular disease risk?

  • Health psychology : official journal of the Division of Health Psychology, American Psychological Association
  • 2015

Similar Papers

Loading similar papers…